In terms of technology, there is a delicate balance between when to adopt cutting-edge products and when to wait, being cautiously optimistic about capabilities but unwilling to waste resources.
CIO is the key for enterprises to understand the application scope of technology, and suggest where to try emerging technology. A successful CIO can balance the modernization of technology core and devote to the development of future business. They also know when to mine suppliers or build products internally. Despite its strong technical capabilities, Johnson & Johnson has weighed the advantages of build and buy, especially when it comes to technologies such as artificial intelligence.
Instead of creating an overall platform, J & J has achieved real success in combining the most advanced machine learning functions with domain expertise.
“You can’t replace scientific and clinical expertise,” Stuart McGuigan, J & J’s chief information officer, told CIO die“ The system is not smart enough to figure out what’s important and what’s not. ” Combining domain expertise – human and machine experts – experts can apply deep learning methods to identify subtle patterns or counterintuitive results.
AI and ml are likely to work across industries, and the potential for healthcare personalization is driving adoption.
Vendors are increasing the scale and adoption of AI tools in healthcare, enabling professionals to leverage machine-based insights in real time. Google is trying to expand deepmind’s streams, a mobile application AI assistant for doctors and nurses. Microsoft is upgrading cloud capabilities to enhance the role of AI in healthcare research and product development.
Johnson & Johnson hopes to apply advanced technology to healthcare to understand individual treatments rather than a subset of patients. Drawing enough data beyond key biometrics or biologics and understanding how individuals operate as individuals can reshape treatment plans.
Our goal is “to be able to customize a very people-oriented treatment plan that contains all of your relevant information, not just that you are diabetic, not just that you have knee pain, not just that you may need to control your weight,” McGregor said“ All of these things are focused on one person, but the health care system is used to seeing them as independent. “
Individualization has a non-conforming special application in the treatment plan, in which the individual may not complete the antibiotic prescription or take the drug twice a day as required. McGuigan said non-compliance is a huge opportunity cost for the health care system. However, if they can expand their personalized and specific interaction with patients, they have the opportunity to solve the problem of individual group non-compliance.
“That’s the scale of artificial intelligence, the scale with a lot of data, in line with behavioral science and clinical understanding.” McGregor said“ This is our future. “